Literature DB >> 29680499

Corrigendum to "Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018" [Drug Resist. Updates 37 (March) (2018) 17-39].

Maria C Sorbo1, Valeria Cento2, Velia C Di Maio1, Anita Y M Howe3, Federico Garcia4, Carlo F Perno5, Francesca Ceccherini-Silberstein1.   

Abstract

Entities:  

Year:  2018        PMID： 29680499     DOI： 10.1016/j.drup.2018.04.001

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN： 1368-7646            Impact factor:   18.500


× No keyword cloud information.
  3 in total

1.  Effects of the Q80K Polymorphism on the Physicochemical Properties of Hepatitis C Virus Subtype 1a NS3 Protease.

Authors:  Allan Peres-da-Silva; Deborah Antunes; André Luiz Quintanilha Torres; Ernesto Raul Caffarena; Elisabeth Lampe
Journal:  Viruses       Date:  2019-07-30       Impact factor: 5.048

2.  Insight into the drug resistance mechanisms of GS-9669 caused by mutations of HCV NS5B polymerase via molecular simulation.

Authors:  Di Han; Huiqun Wang; Baerlike Wujieti; Beibei Zhang; Wei Cui; Bo-Zhen Chen
Journal:  Comput Struct Biotechnol J       Date:  2021-04-20       Impact factor: 7.271

Review 3.  Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges.

Authors:  Thomas F Baumert; Thomas Berg; Joseph K Lim; David R Nelson
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 33.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.